Breast Cancer DESTINY-05

People with breast cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:
• Are a male or female at least 18 years of age
• Have HER2-positive breast cancer
• Have adequate organ function
• Have an interval of no more than 12 weeks between the date of last surgery
• Have completion of neoadjuvant systemic chemotherapy and HER2-directed treatment

You may NOT participate in this study if you:
• Have an uncontrolled infection
• Have unresolved toxicities from previous anticancer therapy
• Have stage IV (metastatic) breast cancer
• Have history of any prior breast cancer
• Have known immunodeficiency virus (HIV) infection, hepatitis B or C
• Are pregnant or breastfeeding

Contact Information
Ambar Baez, Study Coordinator
111 E 210th Street
Bronx, NY 10467
Phone: (718) 920-2006
Email: AMBAEZ@MONTEFIORE.ORG

Metastatic breast cancer

People with unresectable and/or metastatic breast cancer that is human epidermal growth factor receptor 2 (HER2)-low are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age
  • Have unresectable or metastatic breast cancer
  • Have been treated with 1 to 2 prior lines of chemotherapy

You may NOT participate in this study if you:

  • Have a cardiovascular disease
  • Have participated in a radiation therapy or had major surgery within 4 weeks of treatment
  • Have known immunodeficiency virus (HIV) infection, hepatitis B or C infection, or any active infection
  • Are pregnant or breastfeeding

Contact Information
Kathy Lora, Study Coordinator
1695 Eastchester Road
Bronx, NY 10461
Phone: (718) 405-8523
Email: klora@montefiore.org

 

Receptor 2 negative (HR+/HER2-) breast cancer – Astra Zeneca

People with breast cancer are asked to participate in a research study being conducted by Monter Cancer Center.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age
  • Have histologically confirmed HR/HER2-breast cancer
  • Can swallow and retain oral medication

You may NOT participate in this study if you:

  • Have received major surgery within the past 4 weeks
  • Have inadequate bone marrow reserve or organ function
  • Have evidence of dementia
  • Have known immunodeficiency syndrome
  • Are pregnant or breastfeeding

Contact Information
Mary Agnes Templeton, Study Coordinator
450 Lakeville Road Lake Success, NY 11042
Phone: (516) 734-8979
Email: mtempleton@northwell.edu

CheckMate 7A8 – ER+/HER2- Breast Cancer

People with breast cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age or older
  • Have histologically confirmed unilateral invasive breast carcinoma

You may not participate in this study if you:

  • Have received a live/attenuated vaccine within the past 30 days
  • Have known immunodeficiency virus (HIV) infection, hepatitis B or hepatitis C
  • Are pregnant or breastfeeding

Contact Information
Priscilla Vazquez, Study Coordinator
1695 Eastchester Road
Bronx, New York 10461
Phone: (718) 405-8578
Email: pvazquez@montefiore.org

HER2 Negative Advanced Breast Cancer

People with HER2 negative advanced breast cancer are asked to participate in a research study being conducted by Queens Hospital Center.

You may be eligible to participate in this study if you:

  • Are a female at least 18 years of age or older
  • Have histological or cytological proven diagnosis of adenocarcinoma of the breast

You may not participate in this study if you:

  • Have had major surgery within the past 4 weeks
  • Have evidence of either locally advanced not amenable to radiation therapy or surgery in a curative intent, and/or metastatic disease
  • Have any other cancer

Contact Information

Linda Bulone, Study Coordinator
82-68 164th Street Room A541
Jamaica, New York 11432
Phone: (718) 883-3751
Email: BULONEL@NYCHHC.ORG

 

19-06-224 / TX228681

Advanced Breast Cancer with Visceral Metastases

People with advanced breast cancer are asked to participate in a research study being conducted by White Plains Hospital.

You may be eligible to participate in this study if you:

  • Are a female at least 18 years of age or older
  • Have confirmed HR+, HER2- recurrent, locally advanced, unresectable or metastatic breast cancer
  • Are able to swallow tablets

You may not participate in this study if you:

  • Have received a live vaccination within the past 28 days
  • Have known active and clinically relevant bacterial or fungal infection, or detectable viral infection (for example, human immunodeficiency virus or viral hepatitis)
  • Are pregnant, breastfeeding or plan to become pregnant

Contact Information

Joel Victor, Study coordinator
2 Longview Avenue
White Plains, New York 10601
Phone: (914) 849-7591
Email: jvictor1@wphospital.org

 

19-06-219 / TX226746

HER2-negative advanced breast cancer

People with HER2 negative advanced breast cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are an adult female at least 18 years of age or older
  • Have advanced (loco-regionally recurrent or metastatic) breast cancer not amenable to curative therapy

You may not participate in this study if you:

  • Have had major surgery within the past 14 days
  • Are concurrently using other anti-cancer therapy
  • Have known immunodeficiency virus (HIV) infection, hepatitis B or hepatitis C
  • Are pregnant, breastfeeding or plan to become pregnant

Contact Information

Kathy Lora, Study Coordinator
1695 Eastchester Road
Bronx, New York 10461
Phone: (718) 405-8523
Email: klora@montefiore.org

 

19-06-136 / TX226745

IMpassion030 (OPERABLE TRIPLE-NEGATIVE BREAST CANCER)

People with breast cancer are asked to participate in a research study being conducted by Northwell Health.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age or older
  • Have been diagnosed with non-metastatic operable stage II-III breast cancer

You may not participate in this study if you:

  • Have had prior history of invasive breast cancer
  • Have active or history of autoimmune disease or immune deficiency, hepatitis B or C
  • Have had severe infections within the past 4 weeks
  • Are pregnant, breastfeeding or plan to become pregnant
Contact Information

Melissa Ramgadoo, Study Coordinator
450 Lakeville Road
Lake Success, New York 11042
Phone: (516) 734-3584
Email: MRAMGADOO@northwell.edu

IRB #18-06-203-03

Breast Cancer MonarchE

People with Breast Cancer are asked to participate in a research study being conducted by White Plains Hospital.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age
  • Have confirmed diagnosis of HR+, HER2-negative (HER2-), early stage resected invasive breast cancer
  • Have undergone definitive surgical treatment for the current malignancy
  • Are able to swallow oral medications

You may not participate in this study if you:

  • Have Stage IV (M1), Stage IA, and lymph node-negative breast cancer
  • Have previously received treatment with any CDK4 and CDK6 inhibitor
  • Have had surgery within the past 14 days
  • Are pregnant or breastfeeding

Contact Information

Joel Victor, Study Coordinator

2 Longview Avenue, 6th Floor, White Plains, NY 10601

Phone: 914-849-7691

Email: jvictor1@wphospital.org

Breast Cancer

Women with Breast Cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are at least 60 years old
  • Have been diagnosed with having Breast Cancer

You may not participate in this study if you:

  • Have presence of luminal B pathologyHave presence of multifocal calcifications
  • Have a ER AND PR negative, or Her 2 positive noted on pre-cryo biopsy
  • Have presence of multifocal and/or multicentric in breast cancer
  • Have presence of lobular carcinoma

Contact Information

Prena Etchen, Study Coordinator

111 East 210th Street, Bronx, New York 10467

Phone (718) 798-5687

Email: pzagreda@montefiore.org

 

Breast Cancer

People with Breast Cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a female or male and are at least 18 years old
  • Have been diagnosed with having Breast cancer

You may not participate in this study if you:

  • Have stage IV breast cancerAre currently pregnant or lactating
  • Have any allergies or are hypersensitive to the components of the atezolizumab formulation
  • Have bilateral breast cancer
  • Have a history of an autoimmune disease or immune deficiency, including but not limited to: myasthenia gravis, myositis, autoimmune hepatitis, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, antiphospholipid syndrome, Wegener granulomatosis, Sjögren syndrome, Guillain-Barré syndrome, or multiple sclerosis
  •  Are HIV positive
  • Currently have tuberculosis
  • Have had a major surgery within the past month

Contact Information

Lisa Escobar-Peralta, Study Coordinator

1521 Jarret Place, 2nd Floor Bronx, NY 10461

Phone (718) 379-6866

Email: lescobar@montefiore.org